Showing results (1-10 of 95) with videos related to
Sort By:
Pageof 10
Clinical Trials (London, England)|September 25, 2019
Evaluation of irrational dose assignment definitions using the continual reassessment methodNolan A Wages, Evan BagleyStatistics in Medicine|February 25, 2016
Identifying a maximum tolerated contour in two-dimensional dose findingNolan A WagesClinical Trials (London, England)|June 27, 2017
A web application for evaluating Phase I methods using a non-parametric optimal benchmarkNolan A Wages, Nikole VarhegyiJournal of Biopharmaceutical Statistics|June 7, 2014
Seamless Phase I/II Adaptive Design for Oncology Trials of Molecularly Targeted AgentsNolan A Wages, Christopher TaitComputer Methods and Programs in Biomedicine|July 23, 2013
pocrm: an R-package for phase I trials of combinations of agentsNolan A Wages, Nikole VarhegyiStatistics in Biopharmaceutical Research|August 22, 2025
Isotonic Phase I cancer clinical trial design utilizing patient-reported outcomesNolan A Wages, Ruitao LinPharmaceutical Statistics|June 5, 2013
Specifications of a continual reassessment method design for phase I trials of combined drugsNolan A Wages, Mark R ConawayContemporary Clinical Trials Communications|January 6, 2022
Impact of dose feasibility on the conduct of phase I trials of adoptive cell therapyEvan M Bagley, Nolan A WagesStatistics in Biosciences|June 20, 2020
Flexible Phase I-II design for partially ordered regimens with application to therapeutic cancer vaccinesNolan A Wages, Craig L SlingluffClinical Trials (London, England)|December 21, 2019
Adaptive dose-finding based on safety and feasibility in early-phase clinical trials of adoptive cell immunotherapyNolan A Wages, Camilo E FadulPageof 10